Recently a CAS Key Laboratory was approved to be established at the Wuhan Institute of Virology (WIV), CAS, as a platform for etiology and biosafety research on emerging and highly infectious diseases, including Ebola haemorrhagic fever. Once built, it is expected to provide R&D support for the prevention and control of important infectious diseases, as an integral part of the national security...
The stern situation of the current outbreak of Ebola hemorrhagic fever has caught intensive attention from the leadership of CAS. With great concern, repeated instructions have been given, urging the CAS staff to actively provide S&T support for emergency responses to potential invasion of this epidemic, drawing on its buildup in research on emerging and infectious diseases.
Key Laboratory of Etiology and Biosafety for Emerging and Highly Infectious Diseases, Wuhan Institute of Virology, Chinese Academy of Sciences (Laboratory Code: 2014DP173064) was approved to establish recently.
Recently, the project: the Development and Application of Mosquito Larvicide, which is hosted by WIV, has received positive response from local people and successfully got through the examination and inspection conference held in Xinjiang Province.